Haemocompatibility and performance measurement of medical devices
Our core competence is in clinical, preclinical, animal studies as well as in contract research and development. Currently, we provide our services to more than 20 pharmaceutical and medical technology companies in Europe, USA and Japan.
- Haemocompatibility of medical devices according to ISO 10993-4 (e.g. dialysers, oxygenators, transfusion sets)
- Performance measurement of e.g. dialysers according to ISO 8637-1, oxygenators according to ISO 7199, plasma filters according to ISO 8637-3 with human blood/plasma
- Clinical studies for dialysers in close cooperation with a modern, local dialysis centre
- Blood / material interaction (haemocompatibility, inflammation, coagulation)
- MAT test (monocyte activation test)
- Blood oxygenation
- Cell culture and bioreactors
Accreditation
Methods and Studies
eXcorLab GmbH – biochemical and cell biology laboratory
eXcorLab GmbH was founded in 1983 as a biochemical and cell biology laboratory of the Akzo Nobel company and has been working on membrane applications in medicine and biotechnology ever since.
Our current focus is on conducting preclinical studies, which are crucial for the development of innovative medical products. Among other things, we carry out contract research in the fields of nephrology, dialysis, apheresis and cell culture.
A particular area of expertise in our work is haemocompatibility, an essential aspect of ensuring that medical devices and materials interact optimally with human blood and blood components. Through our extensive research and state-of-the-art technologies, we help to ensure the safety and efficacy of new therapies and products. At eXcorLab GmbH, we are passionate about pushing the boundaries of biomedical research and advancing human health.